Picture EBD Group World of Partnering Opportunities 650x100px

Organisation › Details

National Medical Products Administration of China (NMPA, formerly CFDA)

	Start	2018-09-03 renamed before
	Group	China (govt)
	Predecessor	CFDA (Chinese Food and Drug Administration)
	Industry	pharmaceutical

	Region	China_oo
	Country	China
	City	n. a.
		Address record changed: 2018-09-09

Basic data	Employees	n. a.


		Record changed: 2024-04-12

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for China (govt)

[1] Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai....
[2] ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin....
[3] Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin....
[4] Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin....
[5] Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt....
[6] BlueBee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk....
[7] Agilent Technologies Inc.. (10/2/19). "Press Release: Agilent Receives Approval for First PD-L1 Companion Diagnostic in China". Santa Clara, CA....
[8] Agilent Technologies Inc.. (9/19/19). "Press Release: Agilent Presents Thought Leader Award to Professor Hualiang Jiang". Santa Clara, CA....
[9] Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel....
[10] Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]